Impact of Inherited DNA on Cancer Biology Revealed

A new multicenter study by researchers at the Icahn School of Medicine at Mount Sinai, in collaboration with the National Cancer Institute-funded Clinical Proteomic Tumor Analysis Consortium (CPTAC) and colleagues around the world, has discovered that the genes we are born with—known as germline genetic variants—play a powerful, underappreciated role in how cancer develops and behaves. The findings could have major implications for how doctors treat cancer in the future. While current treatments are largely guided by the genetic makeup of a patient’s tumor, this research suggests that looking at a patient’s inherited DNA could further refine diagnosis, risk prediction, and therapy selection. Until now, most cancer research has focused on somatic mutations—changes that occur in cells over a person’s lifetime. But inherited germline variants outnumber somatic mutations by a wide margin, and their impact on cancer has remained poorly understood, say the investigators. To conduct ...